Heron Therapeutics HRTX
NASDAQ HRTX
$0.34 -0.02 (-5.44%)
As of: Oct 21, 2026 · 2:52 PM EDT

Heron Therapeutics (HRTX) EV to EBITDA (2025)

Updated

Heron Therapeutics' EV to EBITDA came in at 44.30 for Q3 2025, down 42.9% from the prior quarter.

Analysis

Heron Therapeutics (HRTX) EV to EBITDA (2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Heron Therapeutics reported EV to EBITDA of 6.30.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn
10 Heron Therapeutics 63.86 Mn -125.71 Mn 26.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 381.11
Sep 30, 2025 37.23
Jun 30, 2025 60.78
API Access

Heron Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=HRTX&period=max&api_key=YOUR_API_KEY